According to Future Market Insights (FMI), the global autoimmune disease testing industry is on a trajectory of robust growth. Estimated at USD 6.07 billion in 2023, the market is projected to expand at a 10% compound annual growth rate (CAGR), reaching an impressive USD 15.75 billion by 2033. This growth is driven by an alarming …